Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
31.9%
% of CANC's 47 holdings also in BBP
24.6%
% of BBP's 65 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
DAY ONE BIOPHARMACEUTICALS, INC. | 1.8% | 1.8% | 1.8% |
|
GILEAD SCIENCES INC | 5.4% | 1.8% | 1.8% |
|
INCYTE CORP | 4.2% | 1.6% | 1.6% |
|
EXELIXIS INC | 3.0% | 1.6% | 1.6% |
|
REGENERON PHARMACEUTICALS | 5.4% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to BBP
 |
ASTRAZENECA PLC | 5.2% |
|
REVOLUTION MEDICINES, INC. | 4.6% |
 |
ARGENX SE ADR | 4.3% |
|
REGENERON PHARMACEUTICALS | 3.9% |
|
ILLUMINA INC | 3.8% |
|
GILEAD SCIENCES INC | 3.7% |
 |
CHUGAI PHARMACEUTICAL CO LTD | 3.3% |
|
DAIICHI SANKYO CO LTD | 3.1% |
|
MERCK & CO. INC. | 2.9% |
|
BLUEPRINT MEDICINES CORP. | 2.8% |
CANC Underweight Relative to BBP
|
MIRUM PHARMACEUTICALS, INC. | -2.4% |
|
ALNYLAM PHARMACEUTICALS INC | -2.1% |
|
TRAVERE THERAPEUTICS, INC. | -2.0% |
|
LIGAND PHARMACEUTICALS-CL B | -1.9% |
|
LEXICON PHARMACEUTICALS, INC. | -1.9% |
|
ACADIA PHARMACEUTICALS INC | -1.9% |
|
BIOCRYST PHARMACEUTICALS INC | -1.8% |
|
IONIS PHARMACEUTICALS, INC. | -1.8% |
|
TG THERAPEUTICS INC | -1.8% |
|
ADMA BIOLOGICS, INC. | -1.8% |